BioCentury
ARTICLE | Clinical News

Azathioprine: SANG completed dosing in its trial

May 28, 1996 7:00 AM UTC

SangStat Medical Corp. (SANG), Menlo Park, Calif. Product: Azathioprine Indication: Immunosuppression in transplant Status: SANG completed dosing in its pilot bioequivalence trial, and has completed G...